These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 2572405)
21. Activation of human natural killer cells by lipopolysaccharide and generation of interleukin-1 alpha, beta, tumour necrosis factor and interleukin-6. Effect of IL-1 receptor antagonist. Conti P; Dempsey RA; Reale M; Barbacane RC; Panara MR; Bongrazio M; Mier JW Immunology; 1991 Aug; 73(4):450-6. PubMed ID: 1833315 [TBL] [Abstract][Full Text] [Related]
22. An in vitro Shwartzman reaction-like response is augmented age-dependently in human peripheral blood mononuclear cells. Motegi A; Kinoshita M; Sato K; Shinomiya N; Ono S; Nonoyama S; Hiraide H; Seki S J Leukoc Biol; 2006 Mar; 79(3):463-72. PubMed ID: 16387840 [TBL] [Abstract][Full Text] [Related]
23. Differential effects of interferon-alpha 2 and interleukin-2 on natural killer cell activity in patients with acquired immune deficiency syndrome. Reddy MM; Chinoy P; Grieco MH J Biol Response Mod; 1984 Aug; 3(4):379-86. PubMed ID: 6332880 [TBL] [Abstract][Full Text] [Related]
24. Lower concentrations of methyl-β-cyclodextrin combined with interleukin-2 can preferentially induce activation and proliferation of natural killer cells in human peripheral blood. Lü HZ; Zhu AY; Chen Y; Tang J; Li BQ Hum Immunol; 2011 Jul; 72(7):538-46. PubMed ID: 21540068 [TBL] [Abstract][Full Text] [Related]
25. Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells. Hirofuji H; Kakumu S; Fuji A; Ohtani Y; Murase K; Tahara H Clin Exp Immunol; 1987 May; 68(2):348-56. PubMed ID: 2820634 [TBL] [Abstract][Full Text] [Related]
26. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor. Chang WC; Hsiao MH; Pattengale PK Nat Immun Cell Growth Regul; 1991; 10(2):57-70. PubMed ID: 1881400 [TBL] [Abstract][Full Text] [Related]
27. Defective NK cell activity following thermal injury. Klimpel GR; Herndon DN; Fons M; Albrecht T; Asuncion MT; Chin R; Stein MD Clin Exp Immunol; 1986 Nov; 66(2):384-92. PubMed ID: 3493101 [TBL] [Abstract][Full Text] [Related]
28. Role of zinc and alpha2 macroglobulin on thymic endocrine activity and on peripheral immune efficiency (natural killer activity and interleukin 2) in cervical carcinoma. Mocchegiani E; Ciavattini A; Santarelli L; Tibaldi A; Muzzioli M; Bonazzi P; Giacconi R; Fabris N; Garzetti GG Br J Cancer; 1999 Jan; 79(2):244-50. PubMed ID: 9888464 [TBL] [Abstract][Full Text] [Related]
29. Modulation of in vitro porcine natural killer cell activity by recombinant interleukin-1 alpha, interleukin-2 and interleukin-4. Knoblock KF; Canning PC Immunology; 1992 Jun; 76(2):299-304. PubMed ID: 1634252 [TBL] [Abstract][Full Text] [Related]
30. A novel role for interleukin-18 in human natural killer cell death: high serum levels and low natural killer cell numbers in patients with systemic autoimmune diseases. Shibatomi K; Ida H; Yamasaki S; Nakashima T; Origuchi T; Kawakami A; Migita K; Kawabe Y; Tsujihata M; Anderson P; Eguchi K Arthritis Rheum; 2001 Apr; 44(4):884-92. PubMed ID: 11315928 [TBL] [Abstract][Full Text] [Related]
31. In vitro effects of IL-2 on NK-activity, clonogenic potential, blast cell proliferation and cytokine release of MDS bone marrow patients. Cortelezzi A; Sarina B; Cattaneo C; Pomati M; Silvestris I; Soligo D; Calori R; Di Stefano M; Hu C; Monza M; Radelli L; Maiolo AT Leukemia; 1996 Jul; 10(7):1181-9. PubMed ID: 8684000 [TBL] [Abstract][Full Text] [Related]
32. Interleukin-6 (IL-6) expression and natural killer (NK) cell dysfunction and anergy in heart failure. Vredevoe DL; Widawski M; Fonarow GC; Hamilton M; Martínez-Maza O; Gage JR Am J Cardiol; 2004 Apr; 93(8):1007-11. PubMed ID: 15081444 [TBL] [Abstract][Full Text] [Related]
33. Natural killer (NK) cells as a responder to interleukin 2 (IL 2). II. IL 2-induced interferon gamma production. Handa K; Suzuki R; Matsui H; Shimizu Y; Kumagai K J Immunol; 1983 Feb; 130(2):988-92. PubMed ID: 6294182 [TBL] [Abstract][Full Text] [Related]
34. Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma). Itoh K; Shiiba K; Shimizu Y; Suzuki R; Kumagai K J Immunol; 1985 May; 134(5):3124-9. PubMed ID: 2984283 [TBL] [Abstract][Full Text] [Related]
35. Long-term killing of natural killer-resistant target cells by interferon-alpha-, interferon-gamma-, and interleukin-2-activated natural killer cells. Sarzotti M; Klimpel GR; Baron S Nat Immun Cell Growth Regul; 1989; 8(2):66-75. PubMed ID: 2503715 [TBL] [Abstract][Full Text] [Related]
36. Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure. Golden-Mason L; Madrigal-Estebas L; McGrath E; Conroy MJ; Ryan EJ; Hegarty JE; O'Farrelly C; Doherty DG Gut; 2008 Aug; 57(8):1121-8. PubMed ID: 18372499 [TBL] [Abstract][Full Text] [Related]
37. Effects of Pityrosporum ovale on proliferation, immunoglobulin (IgA, G, M) synthesis and cytokine (IL-2, IL-10, IFN gamma) production of peripheral blood mononuclear cells from patients with seborrhoeic dermatitis. Neuber K; Kröger S; Gruseck E; Abeck D; Ring J Arch Dermatol Res; 1996 Aug; 288(9):532-6. PubMed ID: 8874748 [TBL] [Abstract][Full Text] [Related]
38. Enhanced production of gamma-interferon by thyroid-derived T cell clones from patients with Hashimoto's thyroiditis. Del Prete GF; Tiri A; Mariotti S; Pinchera A; Ricci M; Romagnani S Clin Exp Immunol; 1987 Aug; 69(2):323-31. PubMed ID: 3115656 [TBL] [Abstract][Full Text] [Related]
39. Natural killer cell mediated cytotoxicity of tumor cells initiated by neem leaf preparation is associated with CD40-CD40L-mediated endogenous production of interleukin-12. Bose A; Baral R Hum Immunol; 2007 Oct; 68(10):823-31. PubMed ID: 17961770 [TBL] [Abstract][Full Text] [Related]
40. Serum levels of IL-12 and the production of IFN-gamma, IL-2 and IL-4 by peripheral blood mononuclear cells (PBMC) in cancer patients treated with Viscum album extract. Kovacs E Biomed Pharmacother; 2000 Jul; 54(6):305-10. PubMed ID: 10989963 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]